Elanco Animal Health Incorporated updated earnings guidance for the second quarter 2024. For the quarter, the company expects revenue to be in range of $1,145 Million to $1,170 Million, reported net income to be in range of $0 to $20 Million, reported earnings per share to be in range of $0.00 to $0.04.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.6 USD | +1.15% | +6.73% | +18.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.12% | 869.76Cr | |
-14.15% | 7.73TCr | |
+25.25% | 371.07Cr | |
+11.99% | 166.25Cr | |
-14.11% | 142.68Cr | |
-0.39% | 130.36Cr | |
-25.46% | 124.65Cr | |
-16.83% | 108.76Cr | |
-6.47% | 98Cr | |
-6.50% | 89Cr |
- Stock Market
- Equities
- ELAN Stock
- News Elanco Animal Health Incorporated
- Elanco Animal Health Incorporated Updates Earnings Guidance for the Second Quarter 2024